Fundz

Raydiant Oximetry raises $7.5M in Series A3 extension round led by Cross-Border Impact Ventures (CBIV) to support clinical studies of Lumerah™ and Daisy™ technologies.

PRIVATEJun 04, 2024

Amount Raised

$7.5 Million

Round Type

Series A

San RamonInformation TechnologyHealth CareMedical

Investors

Cross Border Impact VenturesMarch Of Dimes Innovation FundV CapitalGlobal Health Impact FundRH Capital

Description

Raydiant Oximetry, Inc. announced an oversubscribed $7.5 million Series A3 extension round led by Cross-Border Impact Ventures (CBIV) and syndicated by RH Capital, Global Health Impact Fund, VCapital, and the March of Dimes Innovation Fund. The funding will be used to support two clinical studies of the Lumerah™ and Daisy™ technologies, which aim to improve outcomes for mothers and babies during childbirth.

Quick answer

Raydiant Oximetry, Inc. raised $7.5 Million in a Series A round, dated June 4, 2024. Investors: Cross Border Impact Ventures, March Of Dimes Innovation Fund, V Capital, Global Health Impact Fund and RH Capital. Raydiant Oximetry, Inc. is based in San Ramon, California, United States.

How much did Raydiant Oximetry, Inc. raise?
Raydiant Oximetry, Inc. raised $7.5 Million in a Series A round on June 4, 2024.
Who invested in Raydiant Oximetry, Inc?
Cross Border Impact Ventures, March Of Dimes Innovation Fund, V Capital, Global Health Impact Fund and RH Capital are named as investors in this round.
What does Raydiant Oximetry, Inc. do?
Raydiant Oximetry, Inc. is a company dedicated to the mission of keeping mothers and babies safe during childbirth.
Where is Raydiant Oximetry, Inc. based and how big is it?
Raydiant Oximetry, Inc. is based in San Ramon, California, United States.
Who are the decision-makers at Raydiant Oximetry, Inc?
Fundz holds 1 contact at Raydiant Oximetry, Inc., including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Health Care around the same time

Companies in the same sectors as Raydiant Oximetry, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Novocuff raised $26M (Series A) on July 17, 2024.
  • Loci Orthopaedics raised $14M (Series A) on July 17, 2024.
  • Huma Therapeutics raised $80M (Series D) on July 16, 2024.
  • PulseMedica raised $12M (Pre-Series A) on July 16, 2024.
  • Icanheal raised $1.8M (Seed) on July 16, 2024.
  • Scorpion Therapeutics raised $150M (Series C) on July 16, 2024.

Who to call at Raydiant Oximetry, Inc., and when

A new round usually means Raydiant Oximetry, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Raydiant Oximetry, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Raydiant Oximetry, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Raydiant Oximetry, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Raydiant Oximetry, Inc.

Location

2603 CAMINO RAMON, SUITE 413

San Ramon, California, United States

About

Raydiant Oximetry, Inc. is a company dedicated to the mission of keeping mothers and babies safe during childbirth. It is hard to imagine a greater honor and privilege than working towards this goal. We are developing a low-cost, non-invasive biomedical device to monitor the oxygen levels in fetal blood. This will help obstetricians and patients have more and better information that they need to ensure that it is safe to continue labor or confidently decide that a cesarean section is needed. It is our hope that we will improve maternal and fetal outcomes, decrease cesarean delivery rates, and thus overall decrease healthcare costs worldwide by doing so.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Raydiant Oximetry, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsNeil R., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Raydiant Oximetry, Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Raydiant Oximetry, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.